Axcelis Technologies (ACLS) Lifted to “Sell” at ValuEngine

ValuEngine upgraded shares of Axcelis Technologies (NASDAQ:ACLS) from a strong sell rating to a sell rating in a report released on Wednesday morning.

A number of other research firms also recently commented on ACLS. Needham & Company LLC reaffirmed a buy rating and set a $27.00 price objective on shares of Axcelis Technologies in a research note on Friday, August 3rd. BidaskClub downgraded shares of Axcelis Technologies from a hold rating to a sell rating in a research note on Tuesday, October 9th. B. Riley downgraded shares of Axcelis Technologies from a buy rating to a neutral rating and dropped their price objective for the company from $34.00 to $20.00 in a research note on Monday, October 29th. Craig Hallum raised shares of Axcelis Technologies from a hold rating to a buy rating in a research note on Friday, August 3rd. Finally, Benchmark reaffirmed a buy rating and set a $32.00 price objective on shares of Axcelis Technologies in a research note on Friday, August 3rd. Three research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus price target of $27.00.

Shares of NASDAQ ACLS traded down $0.58 on Wednesday, reaching $17.05. 139,120 shares of the company traded hands, compared to its average volume of 306,136. Axcelis Technologies has a fifty-two week low of $15.72 and a fifty-two week high of $37.05. The company has a market cap of $576.29 million, a P/E ratio of 11.52 and a beta of 0.97.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, November 1st. The semiconductor company reported $0.22 EPS for the quarter, beating the Zacks’ consensus estimate of $0.17 by $0.05. Axcelis Technologies had a net margin of 28.48% and a return on equity of 13.86%. The company had revenue of $95.40 million during the quarter, compared to the consensus estimate of $97.82 million. During the same quarter in the prior year, the company posted $0.35 EPS. The company’s quarterly revenue was down 8.7% compared to the same quarter last year. On average, analysts expect that Axcelis Technologies will post 1.3 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Alps Advisors Inc. increased its position in Axcelis Technologies by 13.4% during the 2nd quarter. Alps Advisors Inc. now owns 20,773 shares of the semiconductor company’s stock worth $596,000 after purchasing an additional 2,457 shares in the last quarter. Globeflex Capital L P increased its position in Axcelis Technologies by 13.6% during the 2nd quarter. Globeflex Capital L P now owns 22,600 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 2,700 shares in the last quarter. Legal & General Group Plc increased its position in Axcelis Technologies by 4.8% during the 1st quarter. Legal & General Group Plc now owns 59,434 shares of the semiconductor company’s stock worth $1,441,000 after purchasing an additional 2,747 shares in the last quarter. OppenheimerFunds Inc. increased its position in Axcelis Technologies by 34.9% during the 2nd quarter. OppenheimerFunds Inc. now owns 13,469 shares of the semiconductor company’s stock worth $267,000 after purchasing an additional 3,486 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in Axcelis Technologies by 2.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 171,176 shares of the semiconductor company’s stock worth $3,390,000 after purchasing an additional 3,618 shares in the last quarter. 84.77% of the stock is owned by hedge funds and other institutional investors.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.

Read More: Call Option

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply